All News

Brand refresh aligns with company‘s purpose to enable healthcare organizations to be “future ready.”

Healthcare Businesswomen’s Association appointment ushers in a new chapter in its mission of advancing women in healthcare.

Pharma should be the ‘glue’ that bonds healthcare organizations together to solve society’s most pressing challenges.

Acquisition is largest in 37-year history of ZS.

California-based healthcare communications firm will be fully integrated into Fingerpaint.

New solution addresses pricing pressures and streamlines order-to-cash process.

What are the reasons behind the slump and what does the future hold?

The recent FDA approval of Biogen’s controversial drug aducanumab is the first drug approved for Alzheimer’s disease in nearly 20 years, and highlights the urgent need for new disease modifying approaches in drug development in this indication.

Janssen has launched series of videos and written perspectives on The Mighty, an online patient network, to highlight the stories of individuals living with pulmonary arterial hypertension (PAH).

It's time to apply the same COVID-19 urgency to other devastating diseases, such as Alzheimer’s, write Andrea Pfeifer and William Mobley.

NURTEC ODT approved for the preventive treatment of adult patients who experience less than 15 headache days per month.

The European Commission’s Genetically Modified Organism (GMO) legislation hurts Europe’s ability to attract clinical trials and delays patient access to transformative medicines, say European industry associations.

Acquisition will enhance Ashfield's Patient Solutions offering.

Becton, Dickinson and Company is to build a $200 million high-tech manufacturing facility in Zaragoza, Spain.

Myrelationshipwithalcohol.com offers educational information about alcohol dependence, an interactive questionnaire developed by the National Institutes of Health.

Deloitte acquires Iperion Life Sciences, which will now run as part of Deloitte’s Risk Advisory function.

Forecast excludes spending on COVID-19 vaccines, according to IQVIA Institute for Human Data Science study.

Specialized Intensive Learning Academies (ILAs) "will deliver transformational training and support across preventative health, value-based health and care, and innovations in health and social care."

Multi-year strategic research collaboration leverages Obsidian’s proprietary cytoDRiVE platform to discover controllable genetic therapies to treat serious diseases.

Ethics and diversity on full display across pharma industry.

A picture of wide manufacturing violations appears in a recently disclosed FDA form 483 report on a site visit to Emergent’s Baltimore vaccine plant.

André Sode, CEO of Liva Healthcare, talks about Liva’s collaboration with Amgen to co-create an innovative digital tele-rehabilitation solution called Rehab+.

Next tier of markets is poised to ascend and offer valuable opportunities to both investors and occupiers.

Healthcare providers across Canada will be able to capture adverse events in the Auxita platform through integration with MyMeds&Me’s pharmacovigilance SaaS platform, Reportum.

This month brings the IR35 tax reform on the UK’s private sector. How will it affect the pharma industry?

New product expands outreach of medical affairs organizations.

A coalition of biopharma and technology leaders have announced a new strategic collaboration to promote new and updated standards for advanced therapies.

Research shows ESG performance is strongly predictive of long-term value creation and financial performance, when a sector-specific approach is maintained.